does retatrutide affect liver significantly improved health in patients with non-alcoholic fatty liver disease Fatty liver disease was alleviated

Nearly a decade on trends, risk factors and policy implications in global obesity

Nature 633 , 758760 (2024)

It has been proven that glucagon-like peptide-1 receptor (GLP-1R) agonists control blood glucose concentrations through a multitude of mechanisms, such as increased satiety, slow stomach emptying, decreased glucagon secretion, and increased insulin synthesis/secretion

The consistent pharmacokinetic profile across injection sites simplifies administration for patients, allowing them to choose sites based on comfort, convenience, and proper rotation practices

GLP-1 decreases appetite, aides in portion control, lessens cravings, and helps trigger insulin release to block sugar production

The STEP 4 trial showed that stopping semaglutide leads to regaining approximately two-thirds of the lost weight within a year